Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma. [electronic resource]
Producer: 20170919Description: 9-16 p. digitalISSN:- 1432-0851
- Animals
- CD8-Positive T-Lymphocytes -- drug effects
- Dose-Response Relationship, Drug
- Humans
- Interleukin-2 -- administration & dosage
- Killer Cells, Natural -- drug effects
- Lymph Nodes -- drug effects
- Male
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred C57BL
- T-Lymphocytes, Regulatory -- drug effects
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.